Most oral blood cancer drug prescriptions were first rejected by insurers, and fill rates fell sharply when out-of-pocket costs topped $175. Most new prescriptions for specialty oral anticancer ...
NP Theresa Stukus and NP Nelli Zafman discuss long-term management considerations for a patient with metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results